Letters to the Editor
Extracorporeal photopheresis and cyclophosphamide for cancer-associated systemic sclerosis worsening induced by immune checkpoint inhibitors: a case report
A. Gaillet1, L. Delage2, M. Wislez3, F. Goupil4, L. Mouthon5, B. Terrier6
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris, France. gaillet.antoine75@gmail.com
- Paris University, Imagine Institute, Laboratory of Immunogenetics of Paediatric Autoimmune Diseases, INSERM UMR 1163, Paris, and Checkpoint Immunology, Immunology and Inflammation Therapeutic Area, Sanofi, Vitry, France.
- Paris Descartes University, Sorbonne Paris Cité; Department of Pulmonology, Thoracic Oncology Unit, Cochin Hospital, Paris, France.
- Pneumology Department, Le Mans Hospital, France.
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris, France.
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris, France.
CER15816
2022 Vol.40, N°10
PI 2004, PF 2005
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35916297 [PubMed]
Received: 04/05/2022
Accepted : 07/06/2022
In Press: 27/07/2022
Published: 17/10/2022
